Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in ALGS — Aligos Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to ALGS Full portfolio

Position in ALGS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$577
-$4,624 QoQ
Shares Held
100
-85.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 31 holders
Holding Since
Dec 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALGS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. ALGS ranks #372 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in ALGS

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $577 100
2026-03-31 $5,201 700
2025-12-31 $13,980 1,500
2025-09-30 $31,066 3,170
2025-06-30 $99,281 13,770
2025-03-31 $189,997 23,030
2024-12-31 $868,512 21,800
2024-03-31 $292 298
2023-12-31 $194 293
2023-09-30 $145 195
2023-06-30 $192 198
2023-03-31 $153 176
2022-12-31 $164 173
2022-09-30 $185 169
2022-06-30 $151 125
2022-03-31 $2,263 1,053
2021-12-31 $101,642 8,563
2021-03-31 $74,337 3,269
2020-12-31 $145,107 5,248